Basic Information
| LncRNA/CircRNA Name | SNHG3 |
| Synonyms | NA |
| Region | GRCh38_1:28505980-28510892 |
| Ensemble | ENSG00000242125 |
| Refseq | NR_002909.1 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | Lung Adenocarcinoma |
| ICD-0-3 | C34 |
| Methods | qPCR |
| Sample | cell lines (A549, NCI-H1299) |
| Expression Pattern | up-regulated |
| Function Description | lncRNA SNHG3 was significantly upregulated in lung adenocarcinoma. We found that SNHG3 promoted proliferation, cell cycle, and suppressed cell apoptosis of lung adenocarcinoma. Upregulation of SNHG3 Predicted a Poor Prognosis in Lung Cancer |
| Pubmed ID | 30154938 |
| Year | 2018 |
| Title | Upregulation of the Long Noncoding RNA SNHG3 Promotes Lung Adenocarcinoma Proliferation. |
External Links
| Links for SNHG3 | GenBank HGNC NONCODE |
| Links for Lung Adenocarcinoma | OMIM COSMIC |